Corporate Events

Nissha Co., Ltd. revised consolidated earnings guidance for the fiscal year January 1, 2026 to December 31, 2026. For the period, the company now expects Net Sales to be JPY 195,000 million against its previous guidance of JPY 198,000 million, Operating loss of JPY 3,300 million against previous guidance of operating profit JPY 7,000 million, Loss attributable to owners of parent of JPY 6,200 million against previous guidance of profit attributable to owners of parent of JPY 3,200 million and basis loss per share guidance of JPY 130.68 against previous guidance of Basic earnings per share of JPY 67.49. Reason for revision: The Company revised downward its full-year business forecast after considering its results for the six months ended June 30, 2026, along with the latest product demand and foreign exchange trends. Net sales are expected to fall below the previous forecast because the anticipated recovery in tablet demand in the Device segment during the second half of the fiscal year is no longer expected. Operating profit, profit before tax, and profit attributable to owners of the parent are also expected to be lower than previously forecast, mainly due to the goodwill impairment loss recorded during the six-month period, weaker demand trends, and costs associated with production in the decorations field of the Industrial Materials segment.

Nissha Co., Ltd., Board Meeting, Sep 04, 2026. Agenda: To consider Transfer of Shares Involving a Change in Consolidated Subsidiary(Specified Subsidiary).

Nissha Co., Ltd., Board Meeting, Aug 13, 2026. Agenda: To consider The semi-annual securities report in question; to consider Filing deadline before the extension; to consider Filing deadline in the event the extension is approved; to consider Reasons for requiring the extension of the filing deadline; and to consider Future outlook.

Nissha Co., Ltd. announced interim dividend of JPY 25.00 per share fiscal year 2026 as compared to JPY 25.00 per share a year ago. Record date is June 30, 2026; Effective date is September 1, 2026; Total Amount of Dividends: JPY 1,200 million; Source of Dividend Retained earnings. For the fiscal year ending December 31, 2026, the company expected dividend of JPY 25.00 per share as compared to JPY 25.00 per share a year ago.

Nissha Co., Ltd. has decided to postpone the announcement of financial results for the second quarter (interim period) of the fiscal year ending December 31, 2026, originally scheduled for August 6, 2026. The reason for the postponement is the ongoing investigation into inappropriate accounting treatments carried out at USM HEALTHCARE MEDICAL DEVICES JOINT STOCK COMPANY during the period prior to its acquisition, which has made it difficult to conduct proper financial closing for USM. The company anticipates that considerable time will be required for the completion of the investigation, the preparation of its consolidated financial statements reflecting the investigation results, and the audit and review procedures by its accounting auditor. The company will promptly announce the rescheduled date for the announcement of financial results and its policy regarding an application for an extension of the filing deadline for the semi-annual securities report once confirmation has been obtained from the relevant parties and its direction has been determined.

Nissha Co., Ltd., Board Meeting, Aug 06, 2026. Agenda: To consider Dividend of Surplus (Interim Dividend).

Reinforcing and Rationalizing the Business Portfolio, Medical Devices CDMO Update

Nissha Co., Ltd. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was JPY 45,790 million compared to JPY 47,442 million a year ago. Net income was JPY 422 million compared to JPY 12 million a year ago. Basic earnings per share from continuing operations was JPY 8.92 compared to JPY 0.26 a year ago.

Nissha Co., Ltd. revised consolidated earnings guidance for first half of FY2026 ending June 30, 2026. For the first half, the company expected net sales of JPY 94,000 million; Operating profit of JPY 1,800 million; Profit attributable to owners of parent of 300 million and Basic earnings per share to be 6.33 as compared to previous guidance of net sales of JPY 87,500 million; Operating profit of JPY 900 million; loss attributable to owners of parent of JPY 1,100 million; and Basic loss per share of JPY 23.21. The company also revised consolidated earnings guidance for the FY2026 ending December 31, 2026. For the year, the company expected net sales of JPY 198,000 million; Operating profit of JPY 7,000 million; Profit attributable to owners of parent of 3,200 million and Basic earnings per share to be 67.49 as compared to previous guidance of net sales of JPY 191,500 million; Operating profit of JPY 6,600 million; profit attributable to owners of parent of JPY 2,300 million; and Basic earning per share of JPY 48.54. Reasons for the revision is For the consolidated business forecast for the first half of FY2026 and FY2026, the Company has considered and reviewed the latest demand trends, foreign exchange movements, and risks of fluctuations in raw material costs arising from turmoil in the Middle East situation comprehensively, based on the results for the three months ended March 31, 2026. Net sales are expected to increase compared to the previous forecast because product demand for the tablet in the Devices segment and the field of decorations in the Industrial Materials segment progressed more than initially expected for the three months ended March 31, 2026, combined with the impact on foreign exchange movements under a weaker yen environment. Operating profit is also expected to exceed the previous forecast, reflecting increased profits driven by higher net sales while taking into account the risks of fluctuations in raw material costs. Furthermore, profit before tax and profit attributable to owners of parent are expected to exceed the previous forecast, due to the above factors, as well as foreign exchange gains recorded during the three months ended March 31, 2026. In addition, the foreign exchange rate assumptions are 155 yen per U.S. dollar for the six months ending June 30, 2026 (previous forecast: 145 yen) and 150 yen per U.S. dollar for the full fiscal year (previous forecast: 145 yen).

Nissha Co., Ltd., Q1 2026 Earnings Call, May 12, 2026

Nissha Co., Ltd. expected to report First-Half, 2026 results on August 6, 2026. This event was calculated by S&P Global (Created on May 9, 2026).

Nissha Co., Ltd., ¥ 25.0, Cash Dividend, Jun-29-2026

Nissha Co., Ltd. announced that they will report Q1, 2026 results on May 12, 2026

Nissha Co., Ltd. has completed a Fixed-Income Offering in the amount of ¥5.5 billion. Security Name: 2.258% Straight Bonds due March 9, 2029 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥5.5 billion Price\Range: 100% Security Features: Unsecured Coupon Type: Fixed

Nissha Co., Ltd. expected to report Q1 2026 results on May 8, 2026. This event was calculated by S&P Global (Created on February 16, 2026).

Nissha Co., Ltd., Annual General Meeting, Mar 24, 2026, at 10:00 Tokyo Standard Time. Location: Company auditorium, 3 Mibu Hanai-cho, Nakagyo-ku, Kyoto, Japan Japan Agenda: To consider the report on the business report, consolidated financial statements for the 107th business term (from January 1, 2025 through December 31, 2025) and the audit results of the accounting auditor and the audit and supervisory board; to consider the report on the non-consolidated financial statements for the 107th business term (from January 1, 2025 through December 31, 2025); to consider the proposal for the election of nine directors of the board; to consider the proposal for the election of one audit and supervisory board member; and to consider other business matters.

Nissha Co., Ltd., Board Meeting, Jan 23, 2026. Agenda: To consider the Notice Regarding Acquisition of Shares of USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY, a Medical Devices Manufacturer in Vietnam, and Making It a Subsidiary.

Nissha Co., Ltd. announced that they will report fiscal year 2025 results on Feb 12, 2026

Nissha Co., Ltd., Board Meeting, Nov 21, 2025. Agenda: To consider the Notice Concerning Cancellation of Treasury Stock.

Nissha Co., Ltd. revised consolidated earnings guidance for the fiscal year ending December 31, 2025. For the year, the company expected net sales of JPY 191,300 million; Operating profit of JPY 3,800 million; Profit attributable to owners of parent and Basic earnings per share to be Nil as compared to previous guidance of net sales of JPY 190,800 million; Operating profit of JPY 6,600 million; Profit attributable to owners of parent of JPY 2,500 million; and Basic earnings per share of JPY 52.80. Reasons for the Revision: For the consolidated business forecast for Fiscal Year 2025, the Company has reviewed the latest demand trends and other relevant factors, considering the results of the nine months ended September 30, 2025. Despite weaker demand for sustainable materials in the Industrial Materials segment and sluggish sales of customer products in contract design/development and manufacturing (CDMO) services of the Medical Technologies segment, Net sales are likely to remain in line with the previous forecast supported by steady demand for tablets in the Devices segment and the commencement of mass production of new products for mobility components in the Industrial Materials segment. However, Operating profit, and Profit attributable to owners of parent are expected to fall below the previous forecast primarily due to upfront expenses related to the launch of mass production of new products for mobility components in the Industrial Materials segment, a decline in demand in sustainable materials for beverages, and stagnant demand in contract design/development and manufacturing (CDMO) services of the Medical Technologies segment.

Nissha Co., Ltd. expected to report Fiscal Year 2025 results on February 13, 2026. This event was calculated by S&P Global (Created on November 8, 2025).

Nissha Co., Ltd. Presents at Medical Design & Manufacturing (MD&M) Midwest 2025, Oct-21-2025 . Venue: Minneapolis Convention Center, Minneapolis, Minnesota, United States.

Informa Markets Limited, Medical Design & Manufacturing (MD&M) Midwest 2025, Oct 21, 2025 through Oct 22, 2025. Venue: Minneapolis Convention Center, Minneapolis, Minnesota, United States.